Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 19 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research

Fee For Service(FFS)

Full Time Equivalent(FTE)

Medicinal Chemistry

Synthetic Chemistry

Analytical Chemistry

Biology Research

Structural Biology

Cell Biology

Computational Biology & Molecular Modeling

Enzymology & Molecular Interactions

Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
APIs

Route Selection

Production Process Optimization

Clinical Sample Production

Impurity Traceability & Control

Generic Drug Process Study & Filing

Innovative Drug Process Study & Filing

Pharmaceutical preparation

Preformulation Study

Formulation Technology Research

Preparation Quality Research

Laboratory-scale Preparation Testing

Pilot-scale Preparation Testing

GMP-based Clinical Sample Production & Packaging

Formulation Stability Study

Consistency Evaluation

Analytical Method Development and Quality Control
CMC Filings
03 Preclinical Research
Pharmacology & Pharmacodynamics

Tumor Models

Digestive System Disease Models

Endocrine & Metabolic Disease Models

Inflammatory & Immune Diseases Models

Neural System Disease Models

Other Disease Models

Drug Safety Evaluation

Pharmacology & Toxicology Study

Safety Pharmacology

Histopathological Study

Clinicopathological Study

Drug Safety Evaluation Basic Information

Toxicokinetics

Pharmacokinetics

In Vitro Pharmacokinetic Assays

In Vivo Pharmacokinetic Assays

Bioanalysis

Macromolecular Drugs Bioanalysis

Micromolecular Drugs Bioanalysis

IND Filings
01 One-stop Integrated Services
Pharmaceutical Research Platform
Drug Discovery Plarform
One-stop API Process R&D Department
Translational Medicine Platform
Pharmaceutical Research CDMO Service Platform
Chemical Drug Development
Medicilon's CDMO Service Platform
Preclinical Research Services
02 Key Technical Services for Drug R&D
Process Department Solid Form Screening Platform
SEND Format Conversion Platform
Flow Cytometry Technology Platform
Safety Assessment Lab of Process Chemistry
Drug Forming Research Platform
Metabolite Identification (MetID) Service Platform
Cytokine and Biomarker Detection Platform
03 Innovative Drug Services
Nucleic Acid Drug R&D Platform
Non-clinical Research for Cellular Immunotherapies
mRNA Vaccine Bioanalysis Platform
PROTAC Drug Discovery Research Platform
ADC R&D Service Platform
04 Drug Efficacy Evaluation for Common Diseases
Rodent Cerebrovascular Disease Drug Efficacy Evaluation System
Pharmacodynamic Evaluation Model Platform for Inflammatory and Immune Diseases
IO Pharmacodynamic Model Evaluation Platform
05 Advanced Preparation R&D
Skin Topical Preparation R&D
Ophthalmic drug R&D platform
Inhalation drug R&D platform
06 Drug Analysis
07 Public Services
CLIENT CENTER
Intellectual Property Protection
Downloads
Partnerships
Newsletters
U.S.

Address: 1 Broadway, Cambridge, MA02142 (America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2023-03-20Market Events
Join Medicilon at SAPA-GP 2023 Annual Conference

Date: 3.31-4.1 2023

Location: King of Prussia, Pennsylvania

Learn more
2023-03-14Market Events
Join Medicilon at BioTrinity 2023: Catalysing Growth in the Life Sciences Industry

Date: April 25-26, 2023

Location: Etc. venues 155 Bishopsgate, London

Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CAREERS
Talent Development
Employee Activities
Campus Recruitment
Social Recruitment
Campus Recruitment
Campus Recruitment
Social Recruitment
Social Recruitment
Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Medicilon Events
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsMedicilon Events

Medicilon Events

Hot information：
Two Innovative Service Platforms of Medicilon were Selected as Shanghai International Service Trade Demonstration project| Medicilon and Wuhan biolake successfully organized a biopharmaceutical salon| Medicilon FTE services & FFS services - flexible and efficient cooperation model
Jan 13,2021
Medicilon was Awarded the Excellent Academician and Expert Workstation of Shanghai and Pudong New Area
Recently, Shanghai Medicilon was awarded the title of "Excellent Expert Workstation” by the Shanghai Academician and Expert Workstation Guidance Office and the title of "2020
More
Medicilon was Awarded the Excellent Academician and Expert Workstation of Shanghai and Pudong New Area
Jan 04,2021
Medicilon's Top 10 Greatest Achievements in 2020
Medicilon embodies its motto of being "Innovation-driven, quality-focused" and keeps on maintaining and improving its technology and quality of services.
More
Medicilon's Top 10 Greatest Achievements in 2020
Jan 01,2021
Medicilon's pharmacology models for inflammatory-immune diseases
Inflammatory immune diseases have gained much attention as the incidence has grown bigger each year. The diseases can affect many parts of human bodies and
More
Medicilon's pharmacology models for inflammatory-immune diseases
Dec 25,2020
Medicilon is Listed as the 2020 TOP10 Innovation CRO in China
Dec.20, 2020, Hebei—The 13th China Pharmaceutical Strategy Conference 2020 was held successfully. The conference presented the list of "the 2020 TOP10 Innovation CRO in China”.
More
Medicilon is Listed as the 2020 TOP10 Innovation CRO in China
Dec 25,2020
Medicilon's CDMO Service Platform
Medicilon has constructed the GMP Drug Products Pilot Plant to meet the rising needs for innovative medicine R&D, production, packaging, inspections and stability tests.
More
Medicilon's CDMO Service Platform
Dec 22,2020
Warmest Holiday Season Greeting From Medicilon 2021
Warmest Holiday Season Greeting From Medicilon. Medicilon wishes you peace,joy and prosperity throughout the coming year.
More
Warmest Holiday Season Greeting From Medicilon 2021
Dec 04,2020
CGeneTech and Medicilon Held the Conference Titled "PROTAC Project Contract Signing & Kick-off Meeting”
Shanghai, China, Dec. 2nd, 2020 — CGeneTech (Suzhou, China) Co., Ltd and Medicilon Inc. successfully held the conference titled "PROTAC project contract signing & kick-off
More
CGeneTech and Medicilon Held the Conference Titled "PROTAC Project Contract Signing & Kick-off Meeting”
Dec 01,2020
Medicilon's Immuno-oncology Models Evaluation Platform
In recent years, tumor immunotherapy has become the core of cancer treatment research. With innovation as the driving force, Medicilon has vigorously developed a tumor
More
Medicilon's Immuno-oncology Models Evaluation Platform
Nov 24,2020
Medicilon Wish You a Safe, Healthy and Warm Thanksgiving
#medicilon #thanksgiving #drugdiscovery
More
Medicilon Wish You a Safe, Healthy and Warm Thanksgiving
Nov 16,2020
Medicilon will participate ACT 2020 Annual Meeting
#Medicilon will exhibit the ACT 2020 Annual Meeting Nov 12-19.  Please visit our virtual booth for our #toxicology services.  We look forward to see you.
More
Medicilon will participate ACT 2020 Annual Meeting
Nov 11,2020
Medicilon will participate SAPA-CT Annual Conference
Medicilon will exhibit the SAPA-CT Annual Conference on Nov 14, 2020.  Our CEO, Dr. Chunlin Chen, is invited to give a presentation on the topic
More
Medicilon will participate SAPA-CT Annual Conference
Oct 31,2020
ABM Therapeutics presented Medicilon with a commemorative trophy of "our first candidate compound"
On October 31, 2020, ABM Therapeutics awarded the "Our First Candidate Compound" commemorative trophy to Dr. Li Zhigang, Vice President of Research and Development of Medicilon Chemistry Department, to thank Medicilon for its FTE form of cooperation, the pharmaceutical and chemical team helped it discover and advance the first drug candidate ABM-1310 to enter the clinical phase I in the United States.
More
ABM Therapeutics presented Medicilon with a commemorative trophy of "our first candidate compound"
Stock Code
688202

Global

Address: 1 Broadway, Cambridge, MA02142 (America)

Tel: +1(626)986-9880(U.S. - West Coast)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 24, Seochojungang-ro 8-gril, Seocho-gu, Seoul, 06643 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->